Ann: Supplementary NYR-BI03 Study Confirm Strong Cardioprotection, page-50

  1. 6,020 Posts.
    lightbulb Created with Sketch. 1928
    It's all good.
    Been through this sort of stuff multiple times and happy to wait until the "stars align".

    NYR is no different ... just another good idea drug with bugger all financial commitment from insiders so far (I'm yet to research the 18% Nox own)

    I see the Q is out. Cash down to $3m ... raise coming up.

    https://hotcopper.com.au/data/attachments/6556/6556487-8e6dacc6afd2c9f27cdfe37491077403.jpg



    Last edited by EWexplorer: 24/10/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.5¢
Change
0.010(4.26%)
Mkt cap ! $51.67M
Open High Low Value Volume
23.0¢ 25.0¢ 23.0¢ $143.6K 590.6K

Buyers (Bids)

No. Vol. Price($)
1 60000 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 159081 1
View Market Depth
Last trade - 15.59pm 20/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.